NAACCR Item #3942: CA 19-9 PreTX Lab Value

Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired
3942 6 NAACCR 2021 21

NAACCR XML: Tumor.ca199PretxLabValue

Alternate Names
   Carbohydrate Antigen 19-9 Pretreatment Lab Value
Description
Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer.
Rationale
CA 19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+.
Codes
0.0 0.0 Units/milliliter (U/ml) exactly
0.1-9999.9 0.1-9999.9 U/ml
Exact value to nearest tenth in U/ml)
XXXX.1 10,000 U/ml or greater
XXXX.2 Lab value not available, physician states CA 19-9 is negative/normal
XXXX.3 Lab value not available, physician states CA 19-9 is positive/elevated/high
XXXX.7 Test ordered, results not in chart
XXXX.8 Not applicable: Information not collected for this case
If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.
XXXX.9 Not documented in medical record
CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value not assessed or unknown if assessed
Blank Diagnosis year is prior to 2021
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.